Citigroup »

Skye Bioscience shares owned by Citigroup

Quarter-by-quarter ownership of Skye Bioscience (SKYE) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Skye Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Skye Bioscience held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Skye Bioscience by Citigroup

Quarter filed Position value Share count Share price at filing
2024-09-30 $49k 13k 3.91
2024-06-30 $31k 3.8k 8.01

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Indl (XLI)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)

View all positions for Citigroup

Top funds holding Skye Bioscience

5AM Venture Management
Versant Venture Management
Baker Bros. Advisors
BlackRock
Schonfeld Strategic Advisors
Ensign Peak Advisors
Driehaus Capital Management
Alyeska Investment Group
Platinum Investment Mangement
Point72 Asset Management
AWM Investment Company
Geode Capital Management
Mirae Asset Global Etfs Holdings
Citadel Advisors
Northern Trust

View all funds holding Skye Bioscience